Patients suffering from severe COVID-19-induced acute respiratory distress syndrome have been described to display elevated levels of Interleukin-6 (IL-6), lymphopenia with low counts of CD8+ T cells, natural killer (NK) and naïve T helper cells, while B cells remained mainly unaffected (11). This evidence concerns the gene CD8A and COVID-19.